JPS61210021A - Hair cosmetic - Google Patents
Hair cosmeticInfo
- Publication number
- JPS61210021A JPS61210021A JP5064285A JP5064285A JPS61210021A JP S61210021 A JPS61210021 A JP S61210021A JP 5064285 A JP5064285 A JP 5064285A JP 5064285 A JP5064285 A JP 5064285A JP S61210021 A JPS61210021 A JP S61210021A
- Authority
- JP
- Japan
- Prior art keywords
- dandruff
- hair
- arbutin
- hair cosmetic
- shampoo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 16
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 24
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N 1,4-Benzenediol Natural products OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 13
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 12
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 12
- 229930182470 glycoside Natural products 0.000 claims abstract description 11
- 239000002253 acid Substances 0.000 claims abstract description 6
- 125000003712 glycosamine group Chemical group 0.000 claims abstract 2
- 150000002338 glycosides Chemical class 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 2
- 125000000625 hexosyl group Chemical group 0.000 claims 1
- 125000001805 pentosyl group Chemical group 0.000 claims 1
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 abstract description 57
- 208000001840 Dandruff Diseases 0.000 abstract description 44
- 229960000271 arbutin Drugs 0.000 abstract description 28
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 abstract description 28
- -1 hydroquinone glycoside Chemical class 0.000 abstract description 20
- 150000001875 compounds Chemical class 0.000 abstract description 5
- 230000003405 preventing effect Effects 0.000 abstract description 4
- 230000007794 irritation Effects 0.000 abstract description 3
- 230000008313 sensitization Effects 0.000 abstract description 3
- 206010070834 Sensitisation Diseases 0.000 abstract description 2
- 239000002453 shampoo Substances 0.000 description 29
- 230000000694 effects Effects 0.000 description 25
- 238000012360 testing method Methods 0.000 description 20
- 239000000203 mixture Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000003205 fragrance Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 6
- 231100000321 erythema Toxicity 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000003676 hair preparation Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 229940075285 dandruff control Drugs 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 3
- 241000700198 Cavia Species 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 3
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229940031957 lauric acid diethanolamide Drugs 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 150000002337 glycosamines Chemical group 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 150000002948 pantothenic acids Chemical class 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001235 sensitizing effect Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- GWEBEJYKXBMRJL-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;1-dodecoxydodecane;sulfuric acid Chemical compound OS(O)(=O)=O.OCCN(CCO)CCO.CCCCCCCCCCCCOCCCCCCCCCCCC GWEBEJYKXBMRJL-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- MSFSPUZXLOGKHJ-PGYHGBPZSA-N 2-amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose Chemical compound OC(=O)[C@@H](C)O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O MSFSPUZXLOGKHJ-PGYHGBPZSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- 241000258740 Abia Species 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-DTEWXJGMSA-N D-Galacturonic acid Natural products O[C@@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-DTEWXJGMSA-N 0.000 description 1
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- BJHIKXHVCXFQLS-PUFIMZNGSA-N D-psicose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-PUFIMZNGSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- IAJILQKETJEXLJ-SQOUGZDYSA-N L-guluronic acid Chemical compound O=C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O IAJILQKETJEXLJ-SQOUGZDYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010070835 Skin sensitisation Diseases 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 101000889883 Sus scrofa Testin Proteins 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 230000000397 acetylating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- GZCGUPFRVQAUEE-KAZBKCHUSA-N aldehydo-D-talose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-KAZBKCHUSA-N 0.000 description 1
- PYMYPHUHKUWMLA-YUPRTTJUSA-N aldehydo-L-lyxose Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-YUPRTTJUSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- AEMOLEFTQBMNLQ-YBSDWZGDSA-N d-mannuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-YBSDWZGDSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000000687 hydroquinonyl group Chemical group C1(O)=C(C=C(O)C=C1)* 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- AEMOLEFTQBMNLQ-CLQWQSTFSA-N l-iduronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O AEMOLEFTQBMNLQ-CLQWQSTFSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 231100000370 skin sensitisation Toxicity 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、頭髪化粧料に関し、更に詳しくは優れたふけ
防止効果を有する頭髪化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to a hair cosmetic, and more particularly to a hair cosmetic having an excellent anti-dandruff effect.
従来の技術
一般に、ふけは皮脂腺の分泌物、汗腺の分泌物、表皮層
の剥離物等からなり、通常は皮脂腺等の分泌抗進により
発生するが、皮膚に細菌や酵母が感染すると、ふけの発
生は病的に助長されるといわれている。このため、従来
から抗菌剤を添加した頭髪化粧料がふけ防止のために使
用されてきた。Conventional technology In general, dandruff consists of secretions from sebaceous glands, secretions from sweat glands, peelings from the epidermal layer, etc., and is usually caused by hypersecretion of sebaceous glands, etc., but when the skin is infected with bacteria or yeast, dandruff The outbreak is said to be facilitated pathologically. For this reason, hair cosmetics containing antibacterial agents have traditionally been used to prevent dandruff.
例えば、ふけ防止用薬剤として最も効果が認められてい
るものとして従来からジンクピリチオン(以下、rZP
TJという)が用いられていることは周知である。しか
しながら、これら抗菌剤は安全性に問題があるものもあ
り、多量に使用することは避けなければならないという
欠点があった。For example, zinc pyrithione (hereinafter referred to as rZP) has been the most effective drug for preventing dandruff.
It is well known that TJ) is used. However, some of these antibacterial agents have safety problems, and their use in large amounts must be avoided.
発明が解決しようとする問題点
前記したような事情に鑑み、本発明者等は、安全性及び
安定性に優れ、かつふけ防止作用に優れた頭髪化粧料を
開発することを目的として鋭意研究を重ねた結果、ハイ
ドロキノンの配糖体が極めて安全性及び安定性に優れ、
単独でふけ防止作用を有し、しかもパントテン酸又はそ
の誘導体と併用した場合に、これらの化合物のふけ防止
作用を著しく高めることができることを認め、本発明を
完成するに至った。Problems to be Solved by the Invention In view of the above-mentioned circumstances, the present inventors have conducted extensive research with the aim of developing a hair cosmetic that is safe and stable, and has an excellent anti-dandruff effect. As a result of repeated efforts, hydroquinone glycosides are extremely safe and stable.
The inventors of the present invention have completed the present invention by recognizing that these compounds have an anti-dandruff effect alone, and can significantly enhance the anti-dandruff effect when used in combination with pantothenic acid or its derivatives.
問題点を解決するための手段
即ち、本発明は、(i)パントテン酸又はその誘導体と
、(ii)下記一般式(1)で表わされるハイドロキノ
ンの配糖体を含有して成る頭髪化粧料を提供する。Means for solving the problem, that is, the present invention provides a hair cosmetic comprising (i) pantothenic acid or a derivative thereof, and (ii) a glycoside of hydroquinone represented by the following general formula (1). provide.
本発明に従った頭髪化粧料は、ふけ防止作用に優れ、し
かも無刺激で感作性がほとんどなく、従って長期連続使
用、高濃度使用も可能である。The hair cosmetic composition according to the present invention has an excellent anti-dandruff effect, is non-irritating and has almost no sensitizing properties, and therefore can be used continuously for a long period of time and in high concentrations.
以下、本発明の構成について更に詳細に説明する。Hereinafter, the configuration of the present invention will be explained in more detail.
本発明で用いるハイドロキノンの配糖体は前記一般式(
1)で示され、式(I)中でRはL−アラビノ、−ス、
D−アラビノース、D−キシロース、D−リボース、L
−キシロース、L−リキソース、D−リブロースなどの
豆炭糖残基、D−グルコース、D−ガラクトース、L−
ガラクトース、D−マンノース、D−タロース、D−フ
ルクトース、L−ソルボース、D−タガトース、D−プ
シコースなどの六炭糖残基;D−グルコサミン、D−ガ
ラクトサミン、シアル酸、アミノウロン酸、ムラミン酸
などのアミノ糖残基;D−グルクロン酸、D−ガラクツ
ロン酸、D−マンヌロン酸、L−イズロン酸、L−グル
ロン酸などのウロン酸残基又はこれらの残基のメチル化
物を示すが、ふけ防止効果、入手の容易性、安定性、安
全性などの面からいえば、RがD−グルコース残基の場
合、特にハイドロキノンにD−グルコースがβ−結合し
た、即ちハイドロキノンβ−D−グルコシド(−船名:
アルブチン、以下単にアルブチンという)の使用が最も
好ましい。The hydroquinone glycoside used in the present invention has the general formula (
1), in formula (I), R is L-arabino, -su,
D-arabinose, D-xylose, D-ribose, L
- Soybean sugar residues such as xylose, L-lyxose, D-ribulose, D-glucose, D-galactose, L-
Hexose residues such as galactose, D-mannose, D-talose, D-fructose, L-sorbose, D-tagatose, D-psicose; D-glucosamine, D-galactosamine, sialic acid, aminouronic acid, muramic acid, etc. Amino sugar residue; refers to uronic acid residues such as D-glucuronic acid, D-galacturonic acid, D-mannuronic acid, L-iduronic acid, and L-guluronic acid, or methylated products of these residues, but is effective in preventing dandruff. In terms of efficacy, availability, stability, safety, etc., when R is a D-glucose residue, D-glucose is β-bonded to hydroquinone, that is, hydroquinone β-D-glucoside (- Ship name:
The use of arbutin (hereinafter simply referred to as arbutin) is most preferred.
かかるハイドロキノンの配糖体のうち、アルブチンは市
販品を使用することができるが、その他のものは、アル
ブチンを含めて、例えばハイドロキノンとアセチル化糖
をオキシ塩化リン、硫酸又は塩化チオニルなどを触媒と
して適当な溶媒中で数時間煮沸還流し、得られた反応生
成物を税アセチル化することによって容易に製造するこ
とができる。なお、これらのハイドロキノンの配糖体は
、単独で、又は任意の混合物として、本発明に係る頭髪
化粧料中に配合することができる。Among such glycosides of hydroquinone, arbutin can be used as a commercially available product, but other glycosides, including arbutin, can be prepared by, for example, combining hydroquinone and acetylated sugar with phosphorus oxychloride, sulfuric acid, or thionyl chloride as a catalyst. It can be easily produced by boiling and refluxing for several hours in a suitable solvent and acetylating the resulting reaction product. In addition, these glycosides of hydroquinone can be blended into the hair cosmetic according to the present invention alone or as an arbitrary mixture.
本発明に係る頭髪化粧料に配合される前記一般式(1)
のハイドロキノンの配糖体の配合量には特に限定はない
が、一般には、頭髪化粧料全量に対して0.01’〜3
0重量%、好ましくは1〜20重量%配合する。この配
合量が0.01ii量%未満ではふけ防止効果が乏しく
なる傾向にあり、逆に、30重量%暮超えて配合しても
効果の増加は実質上望めない。The general formula (1) that is blended into the hair cosmetic according to the present invention
There is no particular limitation on the amount of hydroquinone glycosides, but in general, it is 0.01 to 3% of the total amount of hair cosmetics.
0% by weight, preferably 1 to 20% by weight. If the amount is less than 0.01% by weight, the anti-dandruff effect tends to be poor; on the other hand, if the amount exceeds 30% by weight, no substantial increase in the effect can be expected.
本発明の頭髪化粧料の他の必須成分としてパントテン酸
又はその誘導体を含有する。The hair cosmetic of the present invention contains pantothenic acid or a derivative thereof as another essential ingredient.
本発明に用いるパントテン酸は、自然界に広く分布する
ビタミンB複合体の一種で、下記構造式を有する化合物
である。Pantothenic acid used in the present invention is a type of vitamin B complex widely distributed in nature, and is a compound having the following structural formula.
H3
このものは不安定なため、一般にはカルシウム塩の形で
市販されている。本発明においても、このパントテン酸
カルシウムの形で用いることができる。H3 Because this substance is unstable, it is generally commercially available in the form of a calcium salt. In the present invention, it can also be used in the form of calcium pantothenate.
本発明に用いるパントテン酸の誘導体としてはバントテ
ニルアルコール、バントチティン(バントティン)、バ
ントチチン、バントテニルエチルエーテル、アセチルバ
ントテニルエチルエーテル、ベンゾイルバントテニルエ
チルエーテル、ジカルボエトキシパントテン酸エチルエ
ステル等が挙げられる。Examples of the derivatives of pantothenic acid used in the present invention include bantothenyl alcohol, bantothytin (bantotin), bantothenyl ethyl ether, acetyl bantothenyl ethyl ether, benzoyl bantothenyl ethyl ether, dicarboethoxypantothenic acid ethyl ester, etc. .
本発明においては、これらパントテン酸およびその誘導
体を単独又は任意の混合物の形で配合することができる
。In the present invention, these pantothenic acids and their derivatives can be blended alone or in the form of any mixture.
本発明の頭髪化粧料に配合するパントテン酸又はその誘
導体の配合量には特に限定はないが、一般にはこれらの
化合物の一種又はそれ以上を化粧料中に0.005〜5
重量%配合するのが好ましい。There is no particular limitation on the amount of pantothenic acid or its derivatives to be blended into the hair cosmetic of the present invention, but generally one or more of these compounds is contained in the cosmetic at an amount of 0.005 to 5.
It is preferable to mix it by weight%.
本発明の頭髪化粧料には上記した必須成分の他に通常頭
髪化粧料に用いられる他の成分、例えば油分、紫外線吸
収剤、酸化防止剤、界面活性剤、保湿剤、香料、水、ア
ルコール、増粘剤、防腐剤、色剤、薬剤等を必要に応じ
て適宜配合することができる。In addition to the above-mentioned essential ingredients, the hair cosmetic of the present invention contains other ingredients normally used in hair cosmetics, such as oil, ultraviolet absorbers, antioxidants, surfactants, humectants, fragrances, water, alcohol, Thickeners, preservatives, coloring agents, drugs, etc. can be added as appropriate.
本発明の頭髪化粧料とは、頭皮ないし頭髪に施用される
ものを広く指し、例えばヘアトニック、ヘアリキ・7ド
(液体整髪料)、頭皮用乳液、ヘアクリーム、ヘアシャ
ンプー、ヘアリンス、ヘアスプレー等が含まれる。The hair cosmetics of the present invention broadly refer to those applied to the scalp or hair, such as hair tonics, hair liquids, hair lotions, hair creams, hair shampoos, hair rinses, hair sprays, etc. is included.
発明の効果
次に本発明に用いるハイドロキノンの配糖体の頭髪化粧
料に対する配合効果を明らかにするためにアルブチンを
用いて各種の評価試験を行なった。Effects of the Invention Next, various evaluation tests were conducted using arbutin in order to clarify the effect of blending the hydroquinone glycoside used in the present invention in hair cosmetics.
(1)皮膚累積刺激性
白色モルモット(各群5匹)の背部を毛刈りし、シェー
ビングした後、アルブチンの1%、5%、10%及び2
0%エタノール−水(1: 1)溶液50μtt (
f4液または懸濁液)を−日一回ずつ四日間にわたって
塗布し、刺激の有無を毎日肉眼で判定した。結果を第1
表に示す通りであった。第1表中の数字は刺激の現れた
モルモット数を表わす。(1) Skin cumulative irritation After clipping and shaving the backs of white guinea pigs (5 animals in each group), arbutin concentration of 1%, 5%, 10% and 2
0% ethanol-water (1:1) solution 50 μtt (
f4 liquid or suspension) was applied once every day for four days, and the presence or absence of irritation was visually determined every day. Results first
It was as shown in the table. The numbers in Table 1 represent the number of guinea pigs exposed to stimulation.
第1表の結果から明らかなようにアルブチンは皮膚累積
刺激性が無い化合物である。As is clear from the results in Table 1, arbutin is a compound that does not cause cumulative skin irritation.
第1表
試料 塗布濃度 1日 2日 3日 4日%
(W/V) 後 後 後 後アルブ
チ7 20 0 0 0 0(2)接
触感作性
試験方法:体重370〜420gの健常なモルモットを
使用し、佐原らの方法(Sato Y、+Katsun
+uraY、Ichfkawa H,Kobayash
t T、et aビA ModifiecLTechn
ique of Gufnea Pig Testin
g to IdentityDelayed 1lyp
ersensitivity Allergens”
Contact口ermatitis 7.225−
237.1981)に準じて行なった。Table 1 Sample Application concentration 1st 2nd 3rd 4th %
(W/V) Post Post Post Post Arbuti 7 20 0 0 0 0 (2) Contact sensitization test method: Using healthy guinea pigs weighing 370 to 420 g, Sahara et al.'s method (Sato Y, + Katsun
+uraY, Ichfkawa H, Kobayash
t T, et abiA ModificLTechn
ique of Gufnea Pig Testin
g to IdentityDelayed 1lyp
ersensitivity allergens”
Contact ermatitis 7.225-
237.1981).
判定基準:
(イ)紅斑及び施皮の形成
状態 評点
紅斑の全く認められないもの 0僅かな紅斑
が認められるもの 1明らかな紅斑が認めら
れるもの 2中等度の紅斑が認められるもの
3強い紅斑に僅かな施皮が認められるもの 4
以下余白
(ロ)浮腫の形成
状態 評点
浮腫の全く認められないもの 0僅かな浮腫
が認められるもの 1中等度の浮腫が認めら
れるもの 2強い浮腫が認められるもの
3試料:アルブチンについて試験を実施した。Judgment criteria: (a) Condition of erythema and skin formation Rating: No erythema at all 0: Slight erythema 1: Obvious erythema 2: Moderate erythema
3 Strong erythema with slight peeling 4
Margin below (b) Condition of edema formation Rating: No edema at all 0: Slight edema 1: Moderate edema 2: Strong edema
Three samples were tested: arbutin.
試験結果は第2表に示す通りであった。第2表の結果か
ら明らかなように、アルブチンの感作性が著しく低いこ
とが明らかである。The test results were as shown in Table 2. As is clear from the results in Table 2, it is clear that the sensitizing effect of arbutin is extremely low.
第2表
インプラ チャレン
試 料 ジョン% ジ % 結 果アルブチ
7 5 50/100〃20 20
0/100
(3)経時安定性
処方系における安定性を確認する目的で、後述の実施例
1のシャンプーを使用して安定性試験を行なった。試料
を37℃で1ケ月、2ケ月及び3ケ月保存した後の着色
度を試験したところ、いずれの場合も着色は殆ど認めら
れなかった。この結果からアルブチンの経口安定性が極
めて良好であることが明らかである。Table 2 Implant Challenge Sample John% Di% Result Albuti 7 5 50/100〃20 20
0/100 (3) Stability over time In order to confirm the stability in the formulation system, a stability test was conducted using the shampoo of Example 1 described below. When the degree of coloration was tested after the samples had been stored at 37°C for 1 month, 2 months, and 3 months, almost no coloration was observed in any case. From this result, it is clear that arbutin has extremely good oral stability.
(4)ふけ防止作用効果
アルブチンとパントテン酸又はその誘導体とをシャンプ
ーに配合したシャンプーと、これらを配合しないシャン
プーとのふけ防止効果の評価試験を実施した。(4) Effect of anti-dandruff effect A test was conducted to evaluate the anti-dandruff effect of a shampoo containing arbutin and pantothenic acid or a derivative thereof and a shampoo containing no such ingredients.
実験(1)
精製水(全体で100gになる量)にラウリル硫酸トリ
エタノールアミン15g、ヤシ油脂肪酸ジェタノールア
マイド5g1アルブチン0.1g、パントテン酸0.5
g及び色素、香料を適量・順次添加し加熱後冷却して、
ヘアシャンプー試料A(本発明試料)を得た。Experiment (1) 15 g of triethanolamine lauryl sulfate, 5 g of coconut oil fatty acid jetanolamide, 0.1 g of arbutin, 0.5 g of pantothenic acid in purified water (total amount of 100 g)
g, pigments, and fragrances in appropriate amounts and sequentially, heated and then cooled.
Hair shampoo sample A (sample of the present invention) was obtained.
一方、上記組成においてアルブチン及びパントテン酸を
含まないシャンプーを同様に調製して試料B(コントロ
ール)とした。On the other hand, a shampoo having the above composition but not containing arbutin and pantothenic acid was prepared in the same manner as Sample B (control).
対象者として22〜36オで、ふけの比較的多い男性を
6名選びテストを行なった。The test was conducted on six men between the ages of 22 and 36 who had a relatively large amount of dandruff.
1ケ月間シャンプー試料Bで3日毎に洗髪し、洗髪後3
日間に累積したふけを採集し、採集したふけの平均重量
(コントロール期のふけ量)と、1ケ月間、上記シャン
プー試料Aで3日毎に洗髪し、試験期間終了時の最後の
洗髪後3日間に累積したふけの重量(本発明試験期間)
とを比較した。Wash your hair every 3 days with shampoo sample B for 1 month.
Dandruff accumulated during the day was collected, and the average weight of the collected dandruff (dandruff amount in the control period) was calculated based on the average weight of the collected dandruff (the amount of dandruff in the control period), and the hair was washed every 3 days with the above shampoo sample A for 1 month, and 3 days after the last hair washing at the end of the test period. Weight of accumulated dandruff (test period of the present invention)
compared with.
累積したふけの採集は濾布つき吸引装置を用いて頭部を
吸引することにより行なった。Accumulated dandruff was collected by suctioning the head using a suction device with a filter cloth.
結果は第3表に示す通りであった。The results were as shown in Table 3.
なお、シャンプー使用によるふけの減少率は以下の式で
算出した。The reduction rate of dandruff due to shampoo use was calculated using the following formula.
減少率−〔〔(試験開始前のふけの重量)−(開始1ケ
月後のふけの重量)〕/(試験開始前のふけの重量))
X100 (%)
第3表
被験者 ふけ量(mg) 減少率 平均減少率コ
ント 本発明
ロール 試料 (%) (%)1 19.9
5 13.57 31.982 11.56
6.94 39.97 33.303 9.
23 6.65 27.95実験(II)
上記試料B(コントロール)にアルブチン1gとパント
テンエチルエーテル、パントチチン又はパントチティン
0.05gとを配合してシャンプー試料C,D又はE(
本発明品)を調製した。Reduction rate - [[(Weight of dandruff before the start of the test) - (Weight of dandruff one month after the start of the test)] / (Weight of dandruff before the start of the test))
X100 (%) Table 3 Subject Dandruff amount (mg) Reduction rate Average reduction rate control Invention roll Sample (%) (%) 1 19.9
5 13.57 31.982 11.56
6.94 39.97 33.303 9.
23 6.65 27.95 Experiment (II) Shampoo samples C, D or E (
A product of the present invention) was prepared.
対象者として22〜36オで、ふけの比較的多い男性を
試料毎に3名選び、テストを行なった。For each sample, three men between the ages of 22 and 36 with relatively heavy dandruff were selected for testing.
試験開始前に1ケ月シャンプー試料Bで3日毎に洗髪し
、洗髪後3日間に累積したふけの平均重量(コントロー
ル期の重量)を採集し、採集したふけの平均重量と、1
ケ月間、上記シャンプー試料C,D又はEで洗髪し、試
験期間終了時の最後の洗髪後3日間に累積したふけの重
量(本発明品及び比較品の試験期間)とを比較した。累
積したふけの採集は濾布つき吸引装置を用いて頭部を吸
引することにより行なった。Before the start of the test, hair was washed every 3 days with Shampoo Sample B for 1 month, and the average weight of dandruff accumulated during the 3 days after hair washing (control period weight) was collected, and the average weight of the collected dandruff and 1
The hair was washed with the above-mentioned shampoo samples C, D, or E for several months, and the weight of dandruff accumulated during the three days after the last hair wash at the end of the test period (test period for the inventive product and comparative product) was compared. Accumulated dandruff was collected by suctioning the head using a suction device with a filter cloth.
結果は第4表に示す通りであった。The results were as shown in Table 4.
以下余白
第4表(1)
試料 被験者 ふけ量(mg) 減少率 平均減
少率コント 試験品
ロール (%) (%)C118,05
12,4531,02
27,015,0527,9633,33〃3 14
.39 8.49 41.00D 4 21
.81 15.92 27.01〃5 6.90
5.11 25.94 26.31〃6 1
5.63 11.10 28.98E 7 2
5.97 17.92 30.99〃8 9.6
3 6.93 2B、04 28.34918゜
55 13.73 25.98実施例
次に実施例をあげて本発明を更に詳しく説明するが、本
発明の技術的範囲をこれらの実施例に限定するものでな
いことはいうまでもない。なお、以下の実施例において
配合量は重量%である。Table 4 (1) in the margin below Sample Subject Dandruff amount (mg) Reduction rate Average reduction rate control Test product roll (%) (%) C118,05
12,4531,02 27,015,0527,9633,33〃3 14
.. 39 8.49 41.00D 4 21
.. 81 15.92 27.01〃5 6.90
5.11 25.94 26.31〃6 1
5.63 11.10 28.98E 7 2
5.97 17.92 30.99〃8 9.6
3 6.93 2B, 04 28.34918゜55 13.73 25.98 Examples The present invention will now be explained in more detail with reference to Examples, but the technical scope of the present invention will be limited to these Examples. Needless to say, it is nothing. In addition, in the following examples, the compounding amount is weight %.
実施例1 次の配合組成よりなるシャンプーを調製した。Example 1 A shampoo consisting of the following formulation was prepared.
製造法は前記実験(1)の方法に準じた。The manufacturing method was based on the method of experiment (1) above.
ラウリルサルフェート−Na 5ラウリ
ルサルフェート−トリ
エタノールアミン 5ラウリルジ
メチルアミノ酢酸
ベタイン 6エチレング
リコール脂肪酸エステル 2ポリエチレングリコー
ル 5アルブチン
1パントテニルアルコール 0
.5香料 0.3水
残余このシャン
プーは前記実験例と同様に、5名に対してアルブチン及
びバントテニルアルコール無添加シャンプーとの比較洗
髪試験を行なったところ、5名共、ふけ抑制効果ありと
の判定結果が得られた。Lauryl sulfate-Na 5 Lauryl sulfate-triethanolamine 5 Lauryl dimethylaminoacetic acid betaine 6 Ethylene glycol fatty acid ester 2 Polyethylene glycol 5 Arbutin
1 pantothenyl alcohol 0
.. 5 Fragrance 0.3 Water Residual This shampoo was tested on 5 people in a comparative hair washing test with a shampoo without arbutin and banthothenyl alcohol added, similar to the above experimental example, and all 5 people found it effective in suppressing dandruff. The judgment results were obtained.
実施例2 次の配合組成よりなるシャンプーを調製した。Example 2 A shampoo consisting of the following formulation was prepared.
製造法は実施例1に準じた。The manufacturing method was the same as in Example 1.
ポリオキシエチレン(E、0.平均3モル)ラウリルエ
ーテルサルフェート−Na 10 (重量%)ポ
リオキシエチレン(E、O,平均3モル)ラウリルエー
テルサルフェート
一トリエタノールアミン 7ラウリン酸
ジエタノールアミド 4ジプロピレングリコー
ル 5バントテイン
0.3アルブチン
0.2香料
0.3水 残余こ
のシャンプーは、実施例1と同様に、5名に対してバン
トティン及びアルブチン無添加シャンプーとの比較洗髪
試験を行なったところ、5名共、ふけ抑制効果ありとの
判定結果が得られた。Polyoxyethylene (E, 0.3 mol on average) Lauryl ether sulfate-Na 10 (wt%) Polyoxyethylene (E, O, 3 mol on average) Lauryl ether sulfate - Triethanolamine 7 Lauric acid diethanolamide 4 Dipropylene glycol 5 bunttein
0.3 arbutin
0.2 fragrance
0.3 water remaining This shampoo was subjected to a comparative hair washing test on 5 people as in Example 1 with a shampoo without Bantotin and arbutin added, and all 5 people judged that it had a dandruff suppressing effect. was gotten.
実施例3
次の配合組成よりなるシャンプーをfilli!!した
。Example 3 Filli! shampoo consisting of the following composition: ! did.
製造法は実施例1に準じた。The manufacturing method was the same as in Example 1.
ラウロイルメチルタウリン−Na 10ラウリ
ルジメチルアミノ酢酸
ベタイン 8ラウリン
酸ジエタノールアミド 4エチレングリコール
脂肪酸エステル 1.5ポリエチレングリコール
5パントチチン
0.5アルブチン 3
香料 0.3水
残余このシャンプー
は、実施例1と同様に、5名に対してバントチチン及び
アルブチン無添加シャンプーとの比較洗髪試験を行なっ
たところ、5名共、ふけ抑制効果ありとの判定結果が得
られた。Lauroylmethyltaurine-Na 10 Lauryldimethylaminoacetic acid betaine 8 Lauric acid diethanolamide 4 Ethylene glycol fatty acid ester 1.5 Polyethylene glycol
5 Pantochichin
0.5 Arbutin 3
Fragrance 0.3 water
Residue: Similar to Example 1, this shampoo was subjected to a comparative hair washing test on 5 people with a shampoo without addition of bantochitin or arbutin, and all 5 people judged that it had a dandruff suppressing effect.
実施例4 次の配合組成よりなるシャンプーを調製した。Example 4 A shampoo consisting of the following formulation was prepared.
製造法は実施例1に準じる。The manufacturing method is the same as in Example 1.
ココイルメチルタウリン−Na 10 (
重量%)アルキル(Co)イミダゾリニウム
ベタイン型両性イオン活性剤 6ヤシ脂肪酸ジ
エタノールアミド 4ポリオキシエチレンポリ
オキシブロ
ピレンブロツクポリマ−3
アセチルパントテニルエチル
エーテル 1.0アルブチ
ン 10.0香料
0.3水
残余このシャンプーは実施例1と
同様に、5名に対してアセチルパントテニルエチルエー
テル及びアルブチン無添加シャンプーとの比較洗髪試験
を行なったところ、5名共、ふけ抑制効果ありとの判定
結果が得られた。Cocoyl methyl taurine-Na 10 (
Weight %) Alkyl (Co) imidazolinium betaine type zwitterionic activator 6 Coconut fatty acid diethanolamide 4 Polyoxyethylene polyoxypropylene block polymer 3 Acetyl pantothenyl ethyl ether 1.0 Arbutin 10.0 Fragrance
0.3 water
Residue Similar to Example 1, this shampoo was subjected to a comparative hair washing test on 5 people with a shampoo without the addition of acetyl pantothenyl ethyl ether and arbutin, and all 5 people judged it to have a dandruff suppressing effect. It was done.
実施例5 次の配合組成よりなるシャンプーを調製した。Example 5 A shampoo consisting of the following formulation was prepared.
製造法は実施例1に準じた。The manufacturing method was the same as in Example 1.
ラウロイルサルコシン−Na 10(重
1%)ラウリルジメチルアミノ酢酸
ベタイン 8ラウリン酸
ジエタノールアミド 4ポリオキシプロピレン
ジグリセ
リルエーテル 5ベンゾイルパ
ントテニルエチル
エーテル 0.5アルブチ
ン 0.1香料
0.3水
残余このシャンプーは実施例1と
同様に、5名に対してペンソイルパントテニルエチルエ
ーテル及びアルブチン無添加シャンプーとの比較洗髪試
験を行なったところ、5名共、ふけ抑制効果ありとの判
定結果が得られた。Lauroylsarcosine-Na 10 (1% by weight) Lauryldimethylaminoacetic acid betaine 8 Lauric acid diethanolamide 4 Polyoxypropylene diglyceryl ether 5 Benzoyl pantothenyl ethyl ether 0.5 Arbutin 0.1 Fragrance
0.3 water
Residual Similar to Example 1, this shampoo was subjected to a comparative hair washing test on 5 people with a shampoo without the addition of pensoyl pantothenyl ethyl ether and arbutin, and all 5 people judged that it had a dandruff suppressing effect. Obtained.
実施例6〜8並びに比較例1
第5表に記載の配合組成よりなるヘアリンスを調製し、
そのふけ抑制効果を調べた。製造法は常法によった。Examples 6 to 8 and Comparative Example 1 Hair rinses having the formulations listed in Table 5 were prepared,
We investigated its dandruff suppressing effect. The manufacturing method was a conventional method.
□ 以下余白 □ 第5表 ン。□ Margin below □ Table 5 hmm.
ス一 スラ ボー。Suichi sura baud.
グー。Goo.
アー!
ノ<〉
□ ノイ シ
ラ
ノず 〉
香を
水
ふ番し
効葺
(V
数5
試験は、ふけ防止用薬剤を含まないシャンプー(前記試
料B)で洗髪した後に上記ヘアリンス(コントロール期
には全く比較例1のヘアリンス使用)を用いて行ない、
実施例のシャンプーの場合と同様の方法で、ふけ抑制効
果を調べた。第5表に記載のように、本発明例は、優れ
たふけ抑制効果を示した。Ah!ノ <〉 □ Noi Cyranozu 〉 In the test, the hair was washed with a shampoo that does not contain anti-dandruff drugs (sample B), and then the above hair rinse was applied (no comparative example was used in the control period). 1 using hair rinse),
The dandruff suppressing effect was examined in the same manner as in the case of the shampoo in the example. As shown in Table 5, the examples of the present invention exhibited excellent dandruff suppressing effects.
実施例9 次の配合組成よりなるヘアトニックを調製した。Example 9 A hair tonic having the following composition was prepared.
製造法は水辺外の成分を混合攪拌し、これを水に加えた
。The manufacturing method was to mix and stir ingredients outside the water, and then add this to water.
95%エチルアルコール(専売−級) 50ポリオ
キシエチレン(40モル)硬化
ヒマシ油 0.5パント
テン酸 0.3アルブチン
1.0香料
0.5水
残余このヘアトニックは、優れたふけ
抑制効果を示した。95% ethyl alcohol (proprietary grade) 50 polyoxyethylene (40 mol) hydrogenated castor oil 0.5 pantothenic acid 0.3 arbutin
1.0 fragrance
0.5 water
Residual This hair tonic showed excellent dandruff control effect.
実施例10
次の配合組成よりなるヘアリキッド(液体整髪料)を調
製した。製造法は実施例10に準じる。Example 10 A hair liquid (liquid hair styling product) having the following composition was prepared. The manufacturing method is similar to Example 10.
95%エチルアルコール(専売−級) 50ポリオ
キシプロピレン(40モル)
ブチルエーテル 15ラノリン
1.0パントチチン
10アルブチン
1.0香料
0.5水
残余このヘアリキッドは、優れたふけ抑制効果を示し
た。95% ethyl alcohol (proprietary grade) 50 polyoxypropylene (40 moles) Butyl ether 15 Lanolin
1.0 Pantochitin
10 arbutin
1.0 fragrance
0.5 water
The remaining hair liquid showed excellent dandruff control effect.
実施例11 次の配合組成よりなるヘアクリームを調製した。Example 11 A hair cream having the following composition was prepared.
(A)部を加熱攪拌し、同じく加熱したCB)部に添加
して乳化し、その後冷却して製造した。Part (A) was heated and stirred, added to the similarly heated part CB) to emulsify it, and then cooled to produce the product.
(A)流動パラフィン 15セチル
アルコール 5ワセリン
4グリセリンステアリン酸エステ
ル 3ポリオキシエチレン(20モル)
オレイルアルコール 1パントチテイ
ン 0.5アルブチン
0.5香料
0.5(B)ジプロピレングリコール
10水 残余こ
のO/W型ヘアクリームは、優れたふけ抑制効果を示し
た。(A) Liquid paraffin 15 Cetyl alcohol 5 Vaseline
4 Glycerin stearate 3 Polyoxyethylene (20 mol) Oleyl alcohol 1 Pantocytein 0.5 Arbutin
0.5 fragrance
0.5(B) Dipropylene glycol
10 Water Residual This O/W type hair cream showed excellent dandruff control effect.
実施例12
次の配合組成よりなるヘアローションを調製した。(A
)部を混合攪拌して、(B)部に添加して製造した。Example 12 A hair lotion having the following composition was prepared. (A
) were mixed and stirred and added to part (B) to produce the product.
(A)95%エチルアルコール(専売−級) 40ジ
メチルポリシロキサン 0.5流動パラフ
イン 0.5ポリオキシエチレン
(40モル)0.5硬化ヒマシ油
アクリル樹脂アルカノールアミン液 0.5パントテ
ニルアルコール 0.5ハイドロキノン−
β−り一
アラビノシド 1.0香料
0.2(B)ジプロピレ
ングリコール 3水
残余このヘアローションは、優れたふけ抑
制効果を示した。(A) 95% ethyl alcohol (proprietary grade) 40 Dimethylpolysiloxane 0.5 Liquid paraffin 0.5 Polyoxyethylene (40 moles) 0.5 Hardened castor oil Acrylic resin alkanolamine liquid 0.5 Pantothenyl alcohol 0. 5 Hydroquinone-
β-ri-arabinoside 1.0 fragrance
0.2(B) Dipropylene glycol 3 water
Residual This hair lotion showed excellent dandruff control effect.
実施例13
次の配合組成よりなるヘアローションを調製した。製造
法は実施例12に準じた。Example 13 A hair lotion having the following composition was prepared. The manufacturing method was based on Example 12.
(A)95%エチルアルコール(専売−級)50ジメチ
ルポリシロキサン 2流動パラフイン
2ステアリルトリメチルアンモニ
ウムクロリド 0.3バントテイ
ン 0.1アルブチン
0.1香料
0.2(B)1.3−ブチレングリコール
5水 残余こ
のヘアローションは、優れたふけ抑制効果を示した。(A) 95% ethyl alcohol (proprietary grade) 50 dimethyl polysiloxane 2 liquid paraffin
2 Stearyltrimethylammonium chloride 0.3 Vantothein 0.1 Arbutin
0.1 fragrance
0.2(B) 1.3-butylene glycol
5 Water Residual This hair lotion showed excellent dandruff control effect.
以上製造した実施例1〜13の頭髪化粧料はすべてふけ
防止効果にすぐれ、皮膚刺激性及び感作性が少なく、経
時安定性にもすぐれていた。All of the hair cosmetics of Examples 1 to 13 produced above had excellent anti-dandruff effects, low skin irritation and sensitization, and excellent stability over time.
Claims (1)
一般式( I )で表わされるハイドロキノンの配糖体を
含有して成る頭髪化粧料。 ▲数式、化学式、表等があります▼( I ) 〔式中、Rは五炭糖残基、六炭糖残基、アミノ糖残基、
ウロン酸残基又はこれらの残基のメチル化物を示す。〕 2、成分(i)の合量が0.005〜5重量%である特
許請求の範囲第1項に記載の頭髪化粧料。[Claims] 1. A hair cosmetic comprising (i) pantothenic acid or a derivative thereof and (ii) a glycoside of hydroquinone represented by the following general formula (I). ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (I) [In the formula, R is a pentose residue, a hexose residue, an amino sugar residue,
Indicates uronic acid residues or methylated products of these residues. 2. The hair cosmetic according to claim 1, wherein the total amount of component (i) is 0.005 to 5% by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5064285A JPS61210021A (en) | 1985-03-15 | 1985-03-15 | Hair cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5064285A JPS61210021A (en) | 1985-03-15 | 1985-03-15 | Hair cosmetic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61210021A true JPS61210021A (en) | 1986-09-18 |
| JPH0564611B2 JPH0564611B2 (en) | 1993-09-16 |
Family
ID=12864603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5064285A Granted JPS61210021A (en) | 1985-03-15 | 1985-03-15 | Hair cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61210021A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5364885A (en) * | 1992-11-13 | 1994-11-15 | Ahluwalia Gurpreet S | Reduction of hair growth |
| US5411991A (en) * | 1992-12-22 | 1995-05-02 | Shander; Douglas | Method of reducing hair growth employing sulfhydryl active compounds |
| WO2002076415A1 (en) * | 2001-03-24 | 2002-10-03 | Dietic Dr. Widmann Pharma + Diät Gmbh | Anti-dandruff agent |
| US6743419B1 (en) | 1992-12-22 | 2004-06-01 | The Gillette Company | Method of reducing hair growth employing sulfhydryl active compounds |
| WO2014069566A1 (en) * | 2012-11-02 | 2014-05-08 | ロート製薬株式会社 | External composition for skin |
-
1985
- 1985-03-15 JP JP5064285A patent/JPS61210021A/en active Granted
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5364885A (en) * | 1992-11-13 | 1994-11-15 | Ahluwalia Gurpreet S | Reduction of hair growth |
| US5411991A (en) * | 1992-12-22 | 1995-05-02 | Shander; Douglas | Method of reducing hair growth employing sulfhydryl active compounds |
| US6743419B1 (en) | 1992-12-22 | 2004-06-01 | The Gillette Company | Method of reducing hair growth employing sulfhydryl active compounds |
| WO2002076415A1 (en) * | 2001-03-24 | 2002-10-03 | Dietic Dr. Widmann Pharma + Diät Gmbh | Anti-dandruff agent |
| WO2014069566A1 (en) * | 2012-11-02 | 2014-05-08 | ロート製薬株式会社 | External composition for skin |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0564611B2 (en) | 1993-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0193387B1 (en) | Sunscreen compositions and method of protecting skin | |
| JPS6253917A (en) | Hair cosmetic | |
| JP2958662B2 (en) | Hair growth and hair growth promoter | |
| EP3723714A1 (en) | Propanediol monoacetate mononitrate | |
| US5756079A (en) | Cosmetic compositions containing at least one anionic surfactant of alkylgalactoside uronate type and at least one nonionic surfactant of alkylpolyglycoside and/or polyglycerolated type | |
| US4728667A (en) | Hair treatment composition for prevention of dandruff in hair | |
| JPH0588204B2 (en) | ||
| JP2696523B2 (en) | Anti-dandruff agent and hair cosmetic | |
| JPH0564611B2 (en) | ||
| JPS61197508A (en) | Hair cosmetic for preventing dandruff | |
| JPS61238716A (en) | Hair cosmetic | |
| JPS62153211A (en) | Hair cosmetic | |
| JP3004707B2 (en) | External preparation for skin | |
| JPS61238715A (en) | Hair cosmetic | |
| JPH02145507A (en) | Dandruff preventing cosmetic | |
| KR20020081582A (en) | Hair treatment agent | |
| DE3622641A1 (en) | HAIR CARE PRODUCTS WITH ANTISTATIC EFFECT | |
| JPH10158126A (en) | Hair cosmetic | |
| CA1245986A (en) | Hair treatment composition for prevention of dandruff in hair | |
| JPH01135712A (en) | Head hair cosmetic | |
| JPS62169717A (en) | Hair cosmetic | |
| JPH02145508A (en) | Dandruff-preventing cosmetic | |
| JPS5998011A (en) | Hair cosmetic for preventing dandruff | |
| JPS63211210A (en) | Cosmetic | |
| JPH0853339A (en) | Dermal agent for external use |